Saad M Alshahrani (Saad Alshahrani)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 10

Top Venues

Pharmaceuticals (Basel, Switzerland)

Molecules (Basel, Switzerland)

Nanomaterials (Basel, Switzerland)

International journal of molecular sciences

Prince Sattam bin Abdulaziz University

University of Mississippi (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Prince Sattam bin Abdulaziz University Sep 03 2015

Saudi Arabia

Head of department :: Pharmaceutics

Education History

University of Mississippi Aug 25 2010 - Jul 11 2015

United States

PHD :: Pharmaceutical

Publications

Saad M Alshahrani, Ahmed Al Saqr, Munerah M Alfadhel, Abdullah S Alshetaili, Bjad K Almutairy, Amal M Alsubaiyel, Ali H Almari, Jawaher Abdullah Alamoudi, Mohammad A S Abourehab
Application of CO 2 Supercritical Fluid to Optimize the Solubility of Oxaprozin: Development of Novel Machine Learning Predictive Models. Molecules (Basel, Switzerland) 27 (18) (2022)
El-Sayed Khafagy, Amr Selim Abu Lila, Nahed Mohamed Sallam, Rania Abdel-Basset Sanad, Mahgoub Mohamed Ahmed, Mamdouh Mostafa Ghorab, Hadil Faris Alotaibi, Ahmed S Alalaiwe, Mohammed F Aldawsari, Saad M Alshahrani, Abdullah Alshetaili, Bjad K Almutairy, Ahmed Al Saqr, Shadeed Gad
Preparation and Characterization of a Novel Mucoadhesive Carvedilol Nanosponge: A Promising Platform for Buccal Anti-Hypertensive Delivery. Gels (Basel, Switzerland) 8 (4) (2022)
Saad M Alshahrani
Development and optimization of oral nanoemulsion of rutin for enhancing its dissolution rate, permeability, and oral bioavailability. Pharmaceutical development and technology 27 (5) (2022)
Saad M Alshahrani, El-Sayed Khafagy, Yassine Riadi, Ahmed Al Saqr, Munerah M Alfadhel, Wael A H Hegazy
Amphotericin B-PEG Conjugates of ZnO Nanoparticles: Enhancement Antifungal Activity with Minimal Toxicity. Pharmaceutics 14 (8) (2022)
Randa Mohammed Zaki, Munerah M Alfadhel, Saad M Alshahrani, Ahmed Alsaqr, Layla A Al-Kharashi, M D Khalid Anwer
Formulation of Chitosan-Coated Brigatinib Nanospanlastics: Optimization, Characterization, Stability Assessment and In-Vitro Cytotoxicity Activity against H-1975 Cell Lines. Pharmaceuticals (Basel, Switzerland) 15 (3) (2022)
Ahmed Al Saqr, El-Sayed Khafagy, Ahmed S Alalaiwe, Mohammed F Aldawsari, Saad M Alshahrani, M D Khalid Anwer, Salman Khan, Amr Selim Abu Lila, Hany H Arab, Wael A H Hegazy
Synthesis of Gold Nanoparticles by Using Green Machinery: Characterization and In Vitro Toxicity. Nanomaterials (Basel, Switzerland) 11 (3) (2021)
Mohammed F Aldawsari, Ahmed S Alalaiwe, El-Sayed Khafagy, Ahmed Al Saqr, Saad M Alshahrani, Bader B Alsulays, Sultan M Alshehri, Amr Selim Abu Lila, Syed Mohd Danish Rizvi, Wael A H Hegazy
Efficacy of SPG-ODN 1826 Nanovehicles in Inducing M1 Phenotype through TLR-9 Activation in Murine Alveolar J774A.1 Cells: Plausible Nano-Immunotherapy for Lung Carcinoma. International journal of molecular sciences 22 (13) (2021)
Saad M Alshahrani, Faiyaz Shakeel
Solubility Data and Computational Modeling of Baricitinib in Various (DMSO + Water) Mixtures. Molecules (Basel, Switzerland) 25 (9) (2020)
Bjad K Almutairy, El-Sayed Khafagy, Ahmed S Alalaiwe, Mohammed F Aldawsari, Saad M Alshahrani, Bader B Alsulays, Abdullah S Alshetaili, Sultan M Alshehri, Mohamed H Fayed
Enhancing the Poor Flow and Tableting Problems of High Drug-Loading Formulation of Canagliflozin Using Continuous Green Granulation Process and Design-of-Experiment Approach. Pharmaceuticals (Basel, Switzerland) 13 (12) (2020)
M D Khalid Anwer, Mohammed Muqtader Ahmed, Mohammed F Aldawsari, Saad M Alshahrani, Farhat Fatima, Mohd Nazam Ansari, Najeeb Ur Rehman, Ramadan I Al-Shdefat
Eluxadoline Loaded Solid Lipid Nanoparticles for Improved Colon Targeting in Rat Model of Ulcerative Colitis. Pharmaceuticals (Basel, Switzerland) 13 (9) (2020)

Saad M Alshahrani (Saad Alshahrani)

Publication Activity (10 Years)

Top Topics

Top Venues